Clinical Trials Logo

Filter by:
NCT ID: NCT06165367 Recruiting - Infertility Clinical Trials

Hyaluronan-enriched Medium and Euploid Blastocyst Transfers

GluePloid
Start date: January 15, 2024
Phase: N/A
Study type: Interventional

It has been proposed that enriching transfer media with hyaluronan (EmbryoGlue medium) improves pregnancy outcomes compared with media containing lower concentrations of this molecule. However, none of previous studies included preimplantation genetic testing for aneuploidy (PGT-A) embryos. In order to investigate the impact of this hyaluronan-enriched on pregnancy outcomes, it is essential to evaluate its efficacy on euploid-only embryo transfers. The aim of the present study is to evaluate whether a short period of exposure of euploid blastocysts to EmbryoGlue prior to and during transfer positively impact on pregnancy outcomes of frozen embryo transfer (FET) cycles.

NCT ID: NCT06159465 Completed - Respiratory Failure Clinical Trials

Utility of Defining ARDS and Past and Current Definitions of ARDS

Delphi_ARDS
Start date: December 13, 2023
Phase:
Study type: Observational

Acute Respiratory Distress Syndrome (ARDS), marked by acute hypoxemia and bilateral pulmonary infiltrates, has undergone multiple definitions over the years. Challenges persist regarding the ARDS definitions, leading to various revisions. Through the Delphi study, the investigators aims to gather global opinions on the conceptual framework of ARDS, assess the utility of current and past definitions, and explore the role of subphenotyping. The diverse panel's collective expertise will contribute valuable insights for refining future ARDS definitions and enhancing clinical management.

NCT ID: NCT06156345 Recruiting - Clinical trials for Temporomandibular Disorder

Additional Effect of Forward Head Posture Correction on Temporomandibular Dysfunction

Start date: March 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the additional correction effect of nerd neck on damaged jaw in people who suffers from jaw problems and nerd neck at the same time. The main question it aims to answer: • whether the additional correction of nerd neck impact the jaw features of pain and function. Participants will: - participants will be given the consent to sign first. - participants will be assessed to check jaw pain and function. - participants will be divided randomly into 2 groups. - Each group will be given the treatment sessions for 6 weeks. - participants will come back after 6 weeks for another last assessment. Researchers will compare regular treatment for Jaw with new device, regular only and dental treatment groups to see if there is improvement in jaw characteristics.

NCT ID: NCT06135948 Completed - L-thyroxine Clinical Trials

Impact of Increasing Levothyroxine Dose in Ramadan for UAE Patients With Hypothyroidism

Start date: March 15, 2022
Phase: Phase 4
Study type: Interventional

The study aims to compare the mean change in Thyroid Stimulating Hormone (TSH) levels among patients with hypothyroidism treated with an increased dose of L-thyroxine (treatment group) versus standard/regular dose of L-thyroxine (control group) during the month of Ramadan.

NCT ID: NCT06134713 Active, not recruiting - Post Operative Pain Clinical Trials

Effect of Intra-Canal Cryotherapy on Postoperative Pain After Endodontic Procedures

Start date: May 15, 2023
Phase: Phase 4
Study type: Interventional

The goal of this randomised clinical trial is to evaluate the effect of cryotherapy on postoperative pain after primary and secondary root canal treatment. The main question[s] it aims to answer are: - Dose cryotherapy help reduce postoperative pain after primary root canal treatment. - Dose cryotherapy help reduce postoperative pain after secondary root canal treatment. Participants will be randomly divided to receive either cryotherapy or irrigation with normal saline and the effect between the two groups in terms of postoperative pain will be compared after primary and secondary root canal treatment.

NCT ID: NCT06125314 Recruiting - Breast Cancer Clinical Trials

HER2 TREAT Study: Retrospective Study to Estimate the Prevalence of HER2-low in Unresectable and/or Metastatic Breast Cancer Patients Who Progress on Anti-Cancer Therapy Identified as HER2-Negative From Patient Medical Records in The Gulf Cooperation Council

Start date: March 5, 2024
Phase:
Study type: Observational

HER2-low Breast cancer (BC) has emerged as a new subtype of BC with distinct clinical, pathological, and prognostic features. Little is known about the prevalence of the HER2-low subtype in HER2-negative patients, and previous reports showed variations in the criteria used to define the HER2-low subtype. Besides, data on the clinical features and prognosis of HER2-low patients are limited, and it is still unclear whether HER2-low BC has a prognostic value. Identifying the prevalence and clinical features of HER2-low BC can help establish a more accurate and reproducible definition of HER2-low BC. In the Gulf Cooperation Council (GCC) region, BC is the most common malignancy in women and still poses a significant burden on healthcare resource utilization, moreover, there is only one record for reimbursed HER2 IHC status, categorized as HER2-positive and HER2-negative. It is important to understand the prevalence, clinical features, and outcomes of HER2-low in BC patients from the GCC In this retrospective, non-interventional, multicenter study, the aim to describe the prevalence of HER2-low BC among the current HER2-negative BC population using rescored HER2 IHC samples. The local treatment patterns and the outcomes will be analyzed using the information abstracted from the corresponding medical chart review. The study will cover the GCC region countries (United Arab Emirates [UAE], Saudi Arabia, Qatar, Kuwait, and Oman)

NCT ID: NCT06123585 Completed - Malocclusion Clinical Trials

Artificial Intelligence (AI) Empowered Smile Simulations: Do They Accurately Predict Actual Post Treatment Outcomes

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The aim of the present study is to assess the predictability of Invisalign® SmileView™ for digital AI smile simulation in comparison to actual smile treatment outcomes, using various smile assessment parameters.

NCT ID: NCT06123351 Not yet recruiting - Clinical trials for Temporomandibular Disorder

Forward Head Posture Correction Impact on Temporomandibular Dysfunction

Start date: October 2025
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the effect of nerd neck correction on damaged jaw in people who suffers from jaw problems and nerd neck. The main question it aims to answer: - whether there are different effects of traditional nerd neck correction exercises, device correction method and dental splints on jaw features of pain and function. Participants will: - participants will be given the consent to sign first. - participants will be assessed to check jaw pain and function. - participants will be divided randomly into 3 groups. - Each group will be given the treatment sessions for 6 weeks. - participants will come back after 6 weeks for one last assessment. Researchers will compare traditional, new and dental treatment groups to see if there is improvement in jaw characteristics.

NCT ID: NCT06114030 Recruiting - Caries,Dental Clinical Trials

Clinical and Radiographical Evaluation of CAD-CAM Crowns With and Without Deep Margin Elevation

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Deep margin elevation (DME) is a non-invasive restorative technique to relocate the deep cervical margin to a supragingival position using resin composite. This retrospective multicenter practice-based study will assess the long-term clinical performance and periodontal health of teeth restored with CAD-CAM crowns with or without DME. Patients who will receive CAD-CAM lithium disilicate (LD) crowns with or without DME between 2013 and 2023 at multiple private practices will be included. When indicated, DME will be performed using resin-based restoration. Clinical assessment of the crowns and supporting periodontal structures will be performed following the modified United States Public Health Service (USPHS) criteria. Intra-oral photographs, periapical and bitewing radiographs will be taken for further assessment by three evaluators. Kaplan Meier survival analyses will be performed.

NCT ID: NCT06084988 Recruiting - Clinical trials for Osteo Arthritis Knee

A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis

Start date: November 8, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This open-label, single-arm, phase I/II study in mild-to-moderate stage knee osteoarthritis patients is designed to assess the safety and tolerability of intraarticular human allogeneic bone marrow-derived mesenchymal stromal cell product StromaForte. 12 male and/or female patients aged over 18 years will be enrolled. The main questions it aims to answer are: To assess the safety and tolerability of StromaForte within 24 hours, 4 days ,28 days, 84, and 168 post injection during site visits and post injection by telephone calls. Safety and tolerability will be assessed by reporting the number of adverse events assessed by Common Terminology Criteria For Adverse Events (CTCAE) which is the Incidence of any treatment-emergent serious adverse events (TE-SAEs). Eligible patients will receive one dose (50 x 106 allogeneic bone marrow (BM)-derived MSC formulated in 4 ml infusion solution (sodium chloride supplemented with human serum albumin) to be given via ultrasoundguided intra-articular injection of human allogeneic bone marrow-derived mesenchymal stromal cell product StromaForte